Inato Raises $20 Million in New Funding to Make Clinical Trials More Inclusive
Healthcare IT Today
APRIL 7, 2023
Inato , the leading technology platform enabling access to inclusive clinical trials, today announced the close of $20 million in Series A2 funding from existing and new investors. The fundraise includes return and lead investor Cathay Innovation , return investor Obvious Ventures , as well as new investors La Maison and Top Harvest Capital. The new funding will fuel Inato’s continued product innovation, international growth, and hiring of top talent.
Let's personalize your content